Impact of US Healthcare Reform on the In Vitro Diagnostics Market
Impact of US Healthcare Reform on the In Vitro Diagnostics Market
Patient Influx and Increased Testing Will Steer Clinical Labs toward ACO Models
RELEASE DATE
26-Jun-2014
26-Jun-2014
REGION
North America
North America
Research Code: NE24-01-00-00-00
SKU: LS00046-NA-MR_16887
$2,450.00
In stock
SKU
LS00046-NA-MR_16887
Description
This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segments—immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose—are provided. Key market drivers and restraints and the competitive landscape for the global market are discussed. The base year is 2013.
Table of Contents
Executive Summary
The Patient Protection and Affordable Care Act
Effects on Clinical Labs
Opportunities for IVD Manufacturers and Clinical Labs
Care Delivery Transformation: Acute Care to Prevention
Opportunity Impact Dashboard
Laboratory Test Reimbursement
Factors Affecting Pathology Labs
Most Impacted Specialty
M&As Declined in 2012 and Remained Flat in 2013
6 Factors Affecting the CLFS
Short-term Projection of CLFS Cuts from the ACA
Projected CLFS Reductions
Affordable Care Act Effects
Accountable Care Organizations
Positioning a Clinical Lab within an ACO Ecosystem
Value of Clinical Analytics to a Clinical Lab
Potential Laboratory Strategies
Demands and Expectations of ACOs
Market Segmentation
Market Overview
Key Market Principles
Test Volume by Specialty
Competitive Landscape
Segment Life Cycle Analysis
Decentralization vs. Centralization
Tissue Diagnostics Segment Snapshot
Tissue Diagnostics Segment—US Pricing Analysis
Tissue Diagnostics Segment—Global Strategies
Tissue Diagnostics Segment—Three Big Predictions
Molecular Diagnostics Segment Snapshot
Molecular Diagnostics Segment—Application Areas
Molecular Diagnostics Segment—Market Size and Growth
Molecular Diagnostics Segment—Next-generation Sequencing Snapshot
Molecular Diagnostics Segment—Evolution of NGS Technologies
Molecular Diagnostics Segment—Applications Based on NGS
Molecular Diagnostics Segment—Key NGS Technology Partnerships and Acquisitions
Molecular Diagnostics Segment—Molecular Technologies in Companion Diagnostics
Molecular Diagnostics Segment—Miniaturization
Molecular Diagnostics Segment—Three Big Predictions
Point-of-care Testing Segment Snapshot
Point-of-care Testing Segment—Sales Breakdown
Point-of-care Testing Segment—POCT vs. Laboratory Testing
Point-of-care Testing Segment—Key Trends
Point-of-care Testing Segment—Key Trends (continued)
Point-of-care Testing Segment—Metrics Analysis
Point-of-care Testing Segment—Metrics Analysis (continued)
Point-of-care Testing Segment—Potential Opportunities
Point-of-care Testing Segment—Three Big Predictions
Self-monitoring Blood Glucose Segment Snapshot
Self-monitoring Blood Glucose Segment—Test Strips Market Metrics Analysis
Self-monitoring Blood Glucose Segment—Meters Market Metrics Analysis
Self-monitoring Blood Glucose Segment—Product Analysis
Clinical Microbiology Segment Snapshot
Clinical Microbiology Segment—Microbiology Segmentation
Clinical Microbiology Segment—Emerging Opportunities
Clinical Microbiology Segment—Unmet Demands by Manufacturers
Clinical Microbiology Segment—Technology Trends
Hematology Segment Snapshot
Hemostasis Segment Snapshot
Hematology and Hemostasis Segments—Opportunities for Market Vendors
Immunochemistry Segment Snapshot
Immunochemistry Segment—Installed Base
Conclusions
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
This Market Insight highlights the effects of the US Patient Protection and Affordable Care Act on the in vitro diagnostics (IVD) market, diagnostic test service providers, and IVD manufacturers. The deliverable also focuses on global trends and the outlook for the IVD market. Estimates and trends for all IVD segmentsimmunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucoseare provided. Key market drivers and restraints and the competitive landscape for the global market are discussed. The base year is 2013.
No Index | No |
---|---|
Podcast | No |
Author | Divyaa Ravishankar |
WIP Number | NE24-01-00-00-00 |
Is Prebook | No |